ArticleExperimental & molecular medicine2025

SLC6A14-mediated glutamine promotes SYTL4-CXCL8 axis activation to drive gemcitabine resistance and immune evasion in pancreatic cancer.

Hyeon Woong Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.